Indicator full name: Total health expenditure, purchasing power parity (USD) per capita
Unit: PPP$ per capita
- Country/Area (COUNTRY/AREA)
- Supranational group of countries (COUNTRY_GRP)
- Sex (SEX)
- Year of measure (YEAR)
Years data is available: 1970—2012
Last updated: 01 September 2022
- Bosnia and Herzegovina
- North Macedonia
- Republic of Moldova
- Russian Federation
- San Marino
- Members of the European Union
- Members of the EU before May 2004 (EU15)
- Nordic countries
The following abbreviations are used in the indicator titles:
The WHO Europe Child and Adolescent Health Database (CAHD) provides a set of statistics based on indicators related to the health and well-being of children and adolescents. The statistics were collated from a variety of databases as a joint effort between WHO program divisions and collaborating centres and partners. The database was constructed for the purpose of supporting the Child and Adolescent Health and Development Strategy (2015), providing the relevant information for monitoring progress on child and adolescent health indicators in the 53 member states of the WHO European Region.
Indicator code: E992701.T
For OECD Member States, the data are taken from OECD Health Database (see www.oecd.org). For non-OECD countries, the data are as reported by the country to the HFA-DB and may not necessarily correspond to the common WHO or OECD definition. Adjusted WHO estimates for this indicator, which are generally more accurate, are included as a separate indicator.
Whenever possible, the OECD definition of total expenditure on health is applied (see OECD health systems, Vol. II, page 89, for details). It includes:household health expenses, including goods and services purchased at the consumer's own initiative and the cost-sharing part of publicly financed or supplied care; government-supplied health services including those in schools, prisons and armed forces and special public health programmes such as vaccination; investment in clinics, laboratories etc.; administration costs; research and development, excluding outlays by pharmaceutical firms; industrial medicine; outlays of voluntary and benevolent institutions.In the case of most central and eastern European countries the following has to be included:direct state budget allocated to the health sector, state subsidies to the mandatoryhealth insurance system; mandatory health insurance contributions by employers and employees; direct health expenditure of employers for running industrialmedical facilities; direct health expenditures of ministries and governmental agencies; charity health expenditures; foreign assistance; outstanding debt at the end of the year; private health insurance and direct private health charges. It is important to ensure that funding from the general budget revenues and health insurance contributions do not overlap. For OECD countries data are available from the OECD health database.
Expenditure expressed in “international dollars”. The purchasing power parity (PPP) is adjusted to the relative domestic purchasing power of the national currency as compared to the US dollar, rather than using the official exchange rate. Multipliers (PPPs) are estimated periodically, using the cost of the standard basket of goods.